Published in Ann Surg on June 01, 1999
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut (2005) 3.32
Carcinoid tumors. Oncologist (2008) 2.86
Meckel's diverticulum--a high-risk region for malignancy in the ileum. Insights from a population-based epidemiological study and implications in surgical management. Ann Surg (2011) 2.56
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut (2011) 2.14
An analysis of rare carcinoid tumors: clarifying these clinical conundrums. World J Surg (2005) 1.88
Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut (2007) 1.87
Goblet cell carcinoid of the appendix. World J Surg Oncol (2005) 1.87
Prospective evaluation and treatment of familial carcinoid small intestine neuroendocrine tumors (SI-NETs). Surgery (2015) 1.39
Incidence and management of malignant digestive endocrine tumours in a well defined French population. Gut (2004) 1.39
Multimodal management of neuroendocrine liver metastases. HPB (Oxford) (2010) 1.21
Primary hepatic carcinoid; a diagnostic dilemma: a case report. Cases J (2008) 1.20
Gastrointestinal carcinoid tumors: factors that predict outcome. World J Surg (2004) 1.18
Relationship between clinical characteristics and survival of gastroenteropancreatic neuroendocrine neoplasms: A single-institution analysis (1995-2012) in South China. BMC Endocr Disord (2012) 1.11
Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours. Gut (2006) 1.09
Rare tumors of the colon and rectum: a national review. Int J Colorectal Dis (2006) 1.08
Incidental finding of carcinoid tumor on Meckel's diverticulum: case report and literature review, should prophylactic resection be recommended? World J Surg Oncol (2014) 1.07
Gastrointestinal carcinoids: characterization by site of origin and hormone production. Ann Surg (2000) 1.03
Hepatic neuroendocrine metastases: chemo- or bland embolization? J Gastrointest Surg (2008) 1.02
Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes. Int J Radiat Oncol Biol Phys (2011) 1.01
Pathologic research update of colorectal neuroendocrine tumors. World J Gastroenterol (2010) 0.98
Neuroendocrine liver metastasis treated by using intraarterial therapy: volumetric functional imaging biomarkers of early tumor response and survival. Radiology (2012) 0.98
Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms. Eur J Nucl Med Mol Imaging (2003) 0.97
AKT and PTEN expression in human gastrointestinal carcinoid tumors. Am J Transl Res (2009) 0.94
Treatment of colorectal carcinoids: A new paradigm. World J Gastrointest Surg (2010) 0.93
Laparoscopic versus open resection for appendix carcinoid. Surg Endosc (2006) 0.93
131I-meta-iodobenzylguanidine in the management of metastatic midgut carcinoid tumors. World J Surg (2004) 0.92
Clinicopathological characteristics and prognosis of rectal well-differentiated neuroendocrine tumors. Int J Colorectal Dis (2008) 0.87
Lymph-node metastases in rectal carcinoids. Langenbecks Arch Surg (2008) 0.87
Retrospective analysis of the clinicopathological characteristics of gastrointestinal neuroendocrine neoplasms. Exp Ther Med (2015) 0.86
The clinical features and treatment modality of esophageal neuroendocrine tumors: a multicenter study in Korea. BMC Cancer (2014) 0.85
Epidemiology of small bowel carcinoids in a defined population. World J Surg (2010) 0.85
Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours. Br J Cancer (2013) 0.84
Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis. HPB (Oxford) (2011) 0.82
Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases. Ann Surg Oncol (2008) 0.82
Hepatic resection for metastatic gastrointestinal and pancreatic neuroendocrine tumours: outcome and prognostic predictors. HPB (Oxford) (2007) 0.82
Gastroenteropancreatic neuroendocrine tumour arising in Meckel's diverticulum coexisting with colon adenocarcinoma. World J Surg Oncol (2014) 0.82
Pancreatic neuroendocrine tumors: approach to treatment with focus on sunitinib. Therap Adv Gastroenterol (2013) 0.78
The Phosphatidylinositol 3-kinase/Akt Signaling Pathway in Neuroendocrine Tumors. Glob J Biochem (2011) 0.78
Is an Incidental Meckel's Diverticulum Truly Benign? Case Rep Surg (2015) 0.75
Incidence and survival of patients with small intestinal neuroendocrine tumours in a Danish NET center. ScientificWorldJournal (2012) 0.75
Small bowel carcinoid: a rare cause of bowel obstruction. BMJ Case Rep (2013) 0.75
Prolonged survival in a patient with neuroendocrine tumor of the cecum and diffuse peritoneal carcinomatosis. Case Rep Gastroenterol (2012) 0.75
Incidence and clinical characteristics of gastroenteropancreatic neuroendocrine tumor in Korea: a single-center experience. Korean J Intern Med (2016) 0.75
Gene Expression of Glucose Transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in Gastroenteropancreatic Neuroendocrine Tumors: Correlation with F-18-fluorodeoxyglucose Positron Emission Tomography and Cellular Proliferation. Diagnostics (Basel) (2013) 0.75
The effect of preceding biopsy on complete endoscopic resection in rectal carcinoid tumor. J Korean Med Sci (2014) 0.75
An unusual presentation of "silent" disseminated pancreatic neuroendocrine tumor. World J Gastroenterol (2004) 0.75
Gastric endocrine cell carcinoma with long-term survival developing metachronous remnant cancer. Case Rep Gastroenterol (2011) 0.75
Laparoscopic resection of gastrointestinal neuroendocrine tumors with special contribution of radionuclide imaging. World J Gastroenterol (2014) 0.75
Nonlinear optical microscopy for label-free detection of gastrointestinal neuroendocrine tumors. Lasers Med Sci (2016) 0.75
An analysis of 8305 cases of carcinoid tumors. Cancer (1997) 6.24
Carcinoid tumors. An analysis of 2,837 cases. Cancer (1975) 4.62
The classification of carcinoid tum ours. Lancet (1963) 3.85
Life history of the carcinoid tumor of the small intestine. Cancer (1961) 2.77
Treatment of the carcinoid tumor and the malignant carcinoid syndrome. J Clin Oncol (1983) 2.41
Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases. Cancer (1997) 1.74
Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis. Surgery (1985) 1.64
Carcinoid tumors of the appendix. Ann Surg (1993) 1.36
Carcinoid tumors: a 37-year experience. Arch Surg (1982) 1.35
Malabsorption syndrome associated with metastatic carcinoid tumor. Am J Med (1959) 1.29
Paroxysmal flushing and other symptoms caused by 5-hydroxytryptamine and histamine in patients with malignant tumours. Lancet (1954) 1.25
Rectal carcinoid tumors--treatment and prognosis. Surgery (1983) 1.24
Mesenteric occlusive lesion and ileal carcinoids. Cancer (1979) 1.19
Mesenteric angiopathy, intestinal gangrene, and midgut carcinoids. Surgery (1981) 1.15
Carcinoid tumors of the gastrointestinal tract: a 44-year experience. South Med J (1989) 1.04
Gastrointestinal carcinoid tumors. Am Surg (1991) 1.04
Metastatic carcinoid tumors and the malignant carcinoid syndrome. Acta Oncol (1993) 0.99
Carcinoid tumors: the relationship between clinical presentation and the extent of disease. Surgery (1991) 0.98
Clinical features of carcinoid syndrome and the use of somatostatin analogue in its management. Acta Oncol (1989) 0.98
Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Surgery (1994) 0.92
Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors. AJR Am J Roentgenol (1998) 0.90
Carcinoid tumor of the rectum. DNA ploidy is not a prognostic factor. Dis Colon Rectum (1996) 0.83
Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics (2000) 6.19
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst (1998) 5.30
Computer-based interview for screening blood donors for risk of HIV transmission. JAMA (1992) 4.01
Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet (1997) 3.66
A proportional hazards model for interval-censored failure time data. Biometrics (1986) 3.64
Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med (1996) 3.04
Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer (2000) 2.59
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc Natl Acad Sci U S A (1998) 2.29
Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation (1993) 2.20
Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol (1998) 2.17
Surgical management of phyllodes tumors. Arch Surg (1999) 2.16
The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg (2001) 2.05
Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N Engl J Med (1997) 1.97
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med (1995) 1.89
Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol Genomics (1999) 1.84
Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int (2001) 1.77
Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study. J Clin Oncol (1986) 1.76
Glutamine metabolism by the intestinal tract. JPEN J Parenter Enteral Nutr (1985) 1.71
Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study. J Natl Cancer Inst (1992) 1.70
Superiority of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: a comparison with cardiac catheterization. J Am Coll Cardiol (1988) 1.65
Long-term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated. J Urol (2001) 1.63
Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease. J Thorac Cardiovasc Surg (2001) 1.60
Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review. Br J Dermatol (2014) 1.53
Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. J Clin Oncol (1993) 1.50
Ablation of liver tumors using percutaneous RF therapy. AJR Am J Roentgenol (1998) 1.48
High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer (1997) 1.46
Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma. Cancer J (2000) 1.41
Effect of dietary glutamate on chemotherapy-induced immunosuppression. Nutrition (1999) 1.39
Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant (1998) 1.39
Design considerations for AIDS trials. N Engl J Med (1990) 1.38
The essence of mentoring in academic surgery. J Surg Oncol (2000) 1.35
Modulation of cellular proliferation alters glutamine transport and metabolism in human hepatoma cells. Ann Surg (1994) 1.34
Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys (2001) 1.34
Perception of breast cancer risk among women in breast center and primary care settings: correlation with age and family history of breast cancer. Surgery (1996) 1.33
Prophylactic glutamine protects the intestinal mucosa from radiation injury. Cancer (1990) 1.32
Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. Proc Natl Acad Sci U S A (1996) 1.31
Determinants of accrual of women to a large, multicenter clinical trials program of human immunodeficiency virus infection. The AIDS Clinical Trials Group. J Acquir Immune Defic Syndr (1993) 1.31
A non-parametric maximum likelihood estimator for bivariate interval censored data. Stat Med (1999) 1.30
Predictors of skeletal complications in patients with metastatic breast carcinoma. Cancer (2000) 1.29
A proportional hazards model for multivariate interval-censored failure time data. Biometrics (2000) 1.29
Attitudes and opinions toward surgical research. A survey of surgical residents and their chairpersons. Ann Surg (1996) 1.28
Mouse endostatin inhibits the formation of lung and liver metastases. Cancer Res (1999) 1.27
Minimal-access surgery for staging of malignant melanoma. Arch Surg (1995) 1.27
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. J Clin Oncol (1989) 1.25
Influence of progressive tumor growth on glutamine metabolism in skeletal muscle and kidney. Ann Surg (1993) 1.24
Mechanisms governing the expression of the enzymes of glutamine metabolism--glutaminase and glutamine synthetase. J Nutr (2001) 1.21
Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate. Cancer Res (2000) 1.20
Postoperative alteration of arteriovenous exchange of amino acids across the gastrointestinal tract. Surgery (1983) 1.18
Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer (1999) 1.15
Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology (1998) 1.14
Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. N Engl J Med (1987) 1.13
Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity. Int J Cancer (1993) 1.13
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer. J Clin Oncol (1986) 1.11
A semiparametric model for regression analysis of interval-censored failure time data. Biometrics (1985) 1.11
Surgical treatment and other regional treatments for colorectal cancer liver metastases. Oncologist (1999) 1.06
Glutamine-enriched diets support muscle glutamine metabolism without stimulating tumor growth. J Surg Res (1990) 1.06
An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma. FASEB J (2000) 1.06
Glutamine. World J Surg (2000) 1.05
Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer (2001) 1.04
Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol (1995) 1.04
Glutamine transport in isolated human hepatocytes and transformed liver cells. Hepatology (1995) 1.04
Multimodality management of Merkel cell carcinoma. Arch Surg (1999) 1.04
Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma. Arch Dermatol (2000) 1.03
Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus. Ann Surg (1996) 1.02
Glutamine as a regulator of DNA and protein biosynthesis in human solid tumor cell lines. Ann Surg (1996) 1.01
Relationship between colorectal liver metastases and CEA levels in gallbladder bile. Ann Surg (1989) 1.01
Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg (1999) 1.00
Radiation-induced sarcomas of the chest wall. Cancer (1986) 1.00
A Markov chain Monte Carlo EM algorithm for analyzing interval-censored data under the Cox proportional hazards model. Biometrics (1998) 1.00
Computer interview for screening blood donors for risk of HIV transmission. MD Comput (1994) 1.00
Systemic immunosuppression induced by photodynamic therapy (PDT) is adoptively transferred by macrophages. Photochem Photobiol (1989) 1.00
Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer. Radiother Oncol (2001) 1.00
Intestinal glutamine metabolism after massive small bowel resection. Am J Surg (1990) 1.00
The effects of glutamine-enriched total parenteral nutrition on tumor growth and host tissues. Ann Surg (1992) 0.99
Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia. Am J Med (1995) 0.99
Determinants of glutamine dependence and utilization by normal and tumor-derived breast cell lines. J Cell Physiol (1998) 0.99
Multimodality therapy with a replication-conditional herpes simplex virus 1 mutant that expresses yeast cytosine deaminase for intratumoral conversion of 5-fluorocytosine to 5-fluorouracil. Cancer Res (2001) 0.98
Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: correlation with acute angiography. J Am Coll Cardiol (1988) 0.97
Applying the Cox proportional hazards model when the change time of a binary time-varying covariate is interval censored. Biometrics (1999) 0.97
CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas. Oncogene (1995) 0.97
Growth hormone enhances amino acid uptake by the human small intestine. Ann Surg (1994) 0.96
Cancer gene therapy using a replication-competent herpes simplex virus type 1 vector. Ann Surg (1998) 0.95
Glutamine preserves gut glutathione levels during intestinal ischemia/reperfusion. J Surg Res (1994) 0.95
Delayed central nervous system myelination in the sudden infant death syndrome. J Neuropathol Exp Neurol (1991) 0.95
Gastric and esophageal intraepithelial lymphocytes in pediatric celiac disease. Am J Surg Pathol (1996) 0.95
Outcomes in a series of 103 retroperitoneal sarcomas. Eur J Surg Oncol (2006) 0.94
Intestinal consumption of intravenously administered fuels. JPEN J Parenter Enteral Nutr (1985) 0.94
Glutamine metabolism in sepsis and infection. J Nutr (2001) 0.94